Rosetta Inpharmatics
1996
FOUNDED
M&A
STATUS
101-200
EMPLOYEES
M&A
LATEST DEAL TYPE
3
FINANCING ROUNDS
Description
Provider of an informational genomics platform. The company's integrated platform includes the design and analysis of proprietary DNA microarrays, a powerful, flexible informatics system and advanced molecular biology techniques to support gene expression profiling programs.
Website
Formerly Known As
Rosetta Biosystems
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
- 12040-115th Avenue
- North East
- Kirkland, WA 98034
- United States
Rosetta Inpharmatics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Rosetta Inpharmatics‘s full profile, request access.
Request full access to PitchBookRosetta Inpharmatics Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Rosetta Inpharmatics‘s full profile, request access.
Request full access to PitchBookRosetta Inpharmatics Executive Team (6)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Jasper Rine | Co-Founder | ||
| Stephen Friend | Co-Founder | ||
| Leroy Hood Ph.D | Co-Founder |
3 Former Executives
You’re viewing 3 of 6 executives. Get the full list »